qXR Lung Cancer

CE & Health Canada | Chest | X-ray | Amplifier Partner

Amplifier Marketplace Radiology

Description of use

qXR - Lung Cancer is the world’s most deployed AI tool for early and incidental detection of lung cancer on chest X-rays. Chest X-rays account for the majority of all X-ray types processed globally. By incidentally detecting lung cancer through the identification of lung nodules between 6mm to 30mm, early diagnosis of patients is possible. The tool’s capabilities include the detection and visualization of pulmonary nodules and masses, assigning malignancy scores, and providing pre-populated reports. Patients flagged by qXR can be recommended for follow-up CT scans and added to the early lung cancer pathway.

Benefits of using the qXR LC:

  • Easy setup for a discordance workflow, enabling the detection of EARLY additional/incidental/missed lung nodules, thereby driving more patients to screening.
  • Second-read assistance with pre-populated reports to aid in radiology reads.
  • Enhanced sensitivity and specificity for radiologists.
  • Since not all nodules are cancerous, our proprietary algorithm assigns a risk score to each nodule. This ensures only high-risk patients are followed up, reducing overcalling.

 

 

How is the application integrated?

Can the end-user read the results in IDS7: Yes

DICOM output: DICOM SC, DICOM Encapsulated PDF, DICOM GSPS

Worklist integration: Yes

Pre-populated reports: Yes

Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.

Contact us

Referring articles

The below are peer-reviewed articles that have been submitted by the AI vendor to serve as scientific validation of the application.

Other applications by this vendor

qCT Lung Cancer
CE & Health Canada | CT
Early detection of lung cancer and the management of lung nodules on chest CT scans by detecting lung nodules ranging from 3mm to 30mm with capabilities including volumetry, diameter, localization, texture, calcification, spiculation, malignancy risk, and progression monitoring via adaptable AI.
qER Neurosuite
FDA, CE & Health Canada | CT
Neurosuite timely cares for stroke, traumatic brain injury & injury quantification by detecting and localize up to 12+ abnormalities including ICH and subtypes, midline shift, mass effect, cranial fractures, hypodensities suggesting an Infarct + ASPECTS scoring and cerebral atrophy.
qXR Emergency Room
FDA, CE & Health Canada | X-ray
Abnormal, Atelectasis, Non Aortic Calcification, Cardiomegaly, Cavity, Consolidation, Hyper Inflation, Fibrosis, Opacity, Pleural Effusion, Prominence in Hilar Region, Reticulonodular Pattern, Scoliosis, Tracheal shift, Nodule, Pneumothorax

Let’s talk

Are you interested in learning more? Please do not hesitate to get in touch with us at Sectra.

Contact us

The application content is provided by the respective AI vendors.